Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors
Hirono Tsutsumi, Hiroyuki Inoue, Yoshimasa Shiraishi, Aiko Hirayama, Takayuki Nakanishi, Hiroyuki Ando, Maako Nakajima, Seiji Shinozaki, Hiroaki Ogata, Koji Okamura, Shinichi Kimura, Tomohiro Ogawa, Keiichi Ota, Yasuto Yoneshima, Kentaro Tanaka, Naoki Hamada, Isamu Okamoto, Eiji Iwama
Topics & Concepts
MedicineCalreticulinInternal medicineOncologyLung cancerDampChemotherapyImmune systemNivolumabHazard ratioCancerImmunotherapyGastroenterologyImmunologyEndoplasmic reticulumPhysicsMeteorologyConfidence intervalChemistryBiochemistryCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisInflammasome and immune disorders